Cencora, Inc. (COR) stock
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3021% above fair value
$348.31−2.25 (-0.64%)
Close on Nov 18, 2026Market cap $66.47BP/E 25.9Yield 0.63%
Cencora gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Cencora's gross profit for the twelve months ending Jun 30, 2026 was $13.22B, up 20.0% year over year. For fiscal 2025 it was $11.48B, up 15.8% from the year before. Over ten years it grew 12.5% a year on average. The highest annual figure on record is $11.48B in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $11.48B | +15.8% |
| FY2024 | Sep 30, 2024 | $9.91B | +10.6% |
| FY2023 | Sep 30, 2023 | $8.96B | +8.0% |
| FY2022 | Sep 30, 2022 | $8.30B | +19.5% |
| FY2021 | Sep 30, 2021 | $6.94B | +33.7% |
| FY2020 | Sep 30, 2020 | $5.19B | +1.0% |
| FY2019 | Sep 30, 2019 | $5.14B | +11.4% |
| FY2018 | Sep 30, 2018 | $4.61B | +1.5% |
| FY2017 | Sep 30, 2017 | $4.55B | +6.4% |
| FY2016 | Sep 30, 2016 | $4.27B | +21.1% |
| FY2015 | Sep 30, 2015 | $3.53B | +18.3% |
| FY2014 | Sep 30, 2014 | $2.98B | +18.9% |
| FY2013 | Sep 30, 2013 | $2.51B | -4.8% |
| FY2012 | Sep 30, 2012 | $2.63B | +7.1% |
| FY2011 | Sep 30, 2011 | $2.46B | +5.8% |
| FY2010 | Sep 30, 2010 | $2.33B | +10.7% |
| FY2009 | Sep 30, 2009 | $2.10B | +2.6% |
| FY2008 | Sep 30, 2008 | $2.05B | -7.8% |
| FY2007 | Sep 30, 2007 | $2.22B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $3.61B | +24.1% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $3.59B | +17.3% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $3.07B | +20.1% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $2.95B | +18.5% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $2.91B | +20.6% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $3.06B | +20.6% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $2.56B | +3.6% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $2.49B | +10.6% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $2.41B | +6.5% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $2.54B | +10.6% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $2.47B | +15.0% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $2.25B | +13.5% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $2.26B | +12.4% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $2.30B | +2.7% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $2.15B | +4.2% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $1.99B | -4.1% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $2.02B | +6.7% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $2.24B | +45.8% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $2.06B | +41.9% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $2.07B | +53.6% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $1.89B | +54.0% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $1.53B | +10.5% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $1.45B | +18.0% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $1.35B | +13.7% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $1.23B | -0.4% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $1.39B | -2.6% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $1.23B | -5.1% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $1.18B | +14.7% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $1.23B | +1.6% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $1.42B | +13.5% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $1.30B | +16.6% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $1.03B | -11.9% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $1.21B | +12.2% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $1.26B | -0.1% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $1.11B | +7.2% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $1.17B | +4.2% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $1.08B | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $1.26B | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $1.04B | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $1.12B | – |
See a number that looks wrong?